BBNX's Eversense 365 partnership is likely to broaden CGM choice and strengthen its automated insulin delivery ecosystem across iLet and mint.
(Updates with the latest stock price in the headline and last paragraph.) Beta Bionics (BBNX) rep
Beta Bionics (BBNX) said Tuesday it partnered with Senseonics (SENS) to integrate its iLet Bionic Pa
Senseonics (SENS) has partnered with Beta Bionics (BBNX) to integrate its Eversense 365 continuous g
GERMANTOWN, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in two upcoming investor conferences. Details on the Company’s participation appear below: Lake Street 10th Annual Big Ideas Growth Conference – September 10, 2026 (New York, NY)Management will host o
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Detailed price information for Senseonics Holdings Inc (SENS-Q) from The Globe and Mail including charting and trades.
Senseonics: Q2 Earnings Snapshot
GERMANTOWN, Md., July 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will hold a conference call to review the Company’s second quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The co
This is the newest page. Registered accounts read further back.